Unibest
← Back to patent-cliff list

CAS 228710-82-5

5-Bromo-2-(2,5-dimethyl-1H-pyrrol-1-yl)pyridine

Codes: Dalpiciclib Isethionate-004

Application context (from source-drug indications)

Breast cancerDalpiciclib IsethionateMetastatic breast cancerDalpiciclib IsethionateProstate cancerDalpiciclib Isethionate三阴性乳腺癌Dalpiciclib IsethionateMeningiomaDalpiciclib IsethionateHepatic function declineDalpiciclib Isethionate

Source drugs (routes using this intermediate)

DrugTierExpiry
Dalpiciclib IsethionateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Dalpiciclib IsethionateOptimised routesteps: 4total yield: 52g(Dalpiciclib Isethionate-008)
5-Bromo-2-(2,5-dimethyl-1H-pyrrol-1-yl)pyridine→tert-Butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate→Chlorido[6-(2,5-dimethyl-1H-pyrrol-1-yl)pyridin-3-yl]magnesium→Pyridine→tert-Butyl 6-(2,5-dimethyl-1H-pyrrol-1-yl)[3,4'-bipyridine]-1'(4'H)-carboxylate→tert-Butyl 4-[6-(2,5-dimethyl-1H-pyrrol-1-yl)pyridin-3-yl]piperidine-1-carboxylate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.